Prosecution Insights
Last updated: August 16, 2026

Evolved By Nature Inc.

7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

7
Total Pending OAs
5
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (29%)
3
Medium (43%)
2
Easy (29%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting only2 (29%)
Double-patenting + other3 (43%)
Multi-statute (no §101)2 (29%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAK, MICHAEL D 1 58.5% +30.3%
EIX, EMILY FAY 1 46.7% +76.2%
LEE, HOI YAN NMN 1 41.0% +79.2%
FISCHER, JOSEPH 1 43.3% +45.9%
CREWS, JARET JAMES 1 43.5% +73.8%
KHAN, AMINA S 1 47.4% +43.4%
PARK, HAEJIN S 1 55.1% +38.5%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18002337 Silk-Hyaluronic Acid Compositions For Tissue Filling, Tissue Spacing, and Tissue Bulking LEE, HOI YAN NMN 201d overdue
17604161 CHEMICALLY LINKED SILK FIBROIN COATINGS AND METHODS OF MAKING AND USING THEREOF KHAN, AMINA S 8d

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18002337 Silk-Hyaluronic Acid Compositions For Tissue Filling, Tissue Spacing, and Tissue Bulking LEE, HOI YAN NMN 201d overdue
16626081 SILK-HYALURONIC ACID BASED TISSUE FILERS AND METHODS OF USING THE SAME PARK, HAEJIN S 81d overdue
17604161 CHEMICALLY LINKED SILK FIBROIN COATINGS AND METHODS OF MAKING AND USING THEREOF KHAN, AMINA S 8d
19079960 FIBROIN PEPTIDES AND PROTEIN FRAGMENTS COMPOSITIONS PAK, MICHAEL D
18503064 Silk Protein Fragment Compositions and Articles Manufactured Therefrom EIX, EMILY FAY
17861936 Silk Protein Fragment Compositions and Articles Manufactured Therefrom FISCHER, JOSEPH
17616897 SILK STIMULATED COLLAGEN PRODUCTION AND METHODS OF USE THEREOF CREWS, JARET JAMES

Top Art Units

Art UnitApps
1674 1
1653 1
1693 1
1658 1
1691 1
1761 1
1614 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19079960 FIBROIN PEPTIDES AND PROTEIN FRAGMENTS COMPOSITIONS PAK, MICHAEL D 1674 DP Final Rejection Pending Mar 14, 2025
18503064 Silk Protein Fragment Compositions and Articles Manufactured Therefrom EIX, EMILY FAY 1653 §103§112DP Non-Final OA Pending Nov 06, 2023
18002337 Silk-Hyaluronic Acid Compositions For Tissue Filling, Tissue Spacing, and Tissue Bulking LEE, HOI YAN NMN 1693 §102§103§112Other Non-Final OA 201d overdue Pending Dec 19, 2022
17861936 Silk Protein Fragment Compositions and Articles Manufactured Therefrom FISCHER, JOSEPH 1658 DP Non-Final OA Pending Jul 11, 2022
17616897 SILK STIMULATED COLLAGEN PRODUCTION AND METHODS OF USE THEREOF CREWS, JARET JAMES 1691 §103DP Non-Final OA Pending Dec 06, 2021
17604161 CHEMICALLY LINKED SILK FIBROIN COATINGS AND METHODS OF MAKING AND USING THEREOF KHAN, AMINA S 1761 §103§112Other Final Rejection 8d Pending Oct 15, 2021
16626081 SILK-HYALURONIC ACID BASED TISSUE FILERS AND METHODS OF USING THE SAME PARK, HAEJIN S 1614 §103DP Non-Final OA 81d overdue Pending Dec 23, 2019

Managing Evolved By Nature Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month